Shares of Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Free Report) rose 1.1% during trading on Monday . The stock traded as high as $25.55 and last traded at $25.55. Approximately 366 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 3,595 shares. The stock had previously closed at $25.26.
Virtus LifeSci Biotech Clinical Trials ETF Price Performance
The company’s 50 day simple moving average is $26.56 and its 200 day simple moving average is $26.73.
Virtus LifeSci Biotech Clinical Trials ETF Company Profile
The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.
Featured Stories
- Five stocks we like better than Virtus LifeSci Biotech Clinical Trials ETF
- Consumer Staples Stocks, Explained
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Bank Stocks – Best Bank Stocks to Invest In
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- What Are Growth Stocks and Investing in Them
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Virtus LifeSci Biotech Clinical Trials ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg?v=20221221064411&h=45&w=95&zc=2){kind=logo}
